We are aware of shortages of multiple intravenous (IV) fluid products from all three Australian suppliers (Baxter Healthcare, B.Braun, and Fresenius Kabi).
The shortages are due to multiple factors including global supply limitations, unexpected increases in demand, and manufacturing issues.
To minimise the impact of these shortages, we have approved multiple overseas-registered alternative saline fluids under section 19A of the Therapeutic Goods Act 1989.
We will continue to monitor the supply and work closely with the sponsors and state and territory health departments to reduce the impact of the shortage.
Please visit About the shortage of intravenous (IV) fluids for more information.
Topics